XML 45 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Total Operating Expenses $ 3,182,112 $ 2,806,574
Stock-Based Compensation Expenses $ 39,087 35,486
Common Shares Available for Grant 12,900,000  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 1 year 10 months 24 days  
Stock Options and SARs    
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Stock-based compensation expense related to stock options, SAR and ESPP grants $ 13,900 $ 12,000
Unrecognized compensation expense [1] $ 94,600  
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]    
Weighted Average Fair Value of Grants (price per share) $ 27.19 $ 28.19
Expected Volatility (in hundredths) 31.81% 29.01%
Risk-Free Interest Rate (in hundredths) 2.51% 2.09%
Dividend Yield (in hundredths) 0.88% 0.66%
Expected Life (in years) 5 years 5 years
Stock Options and SARs Rollforward [Abstract]    
Outstanding at January 1 (in shares) 8,310,000 9,103,000
Granted (in shares) 17,000 16,000
Exercised (1) (in shares) [1] (43,000) (752,000)
Forfeited (in shares) (48,000) (77,000)
Outstanding at March 31 (2) (in shares) [2] 8,236,000 8,290,000
Stock Options and SARs Vested or Expected to Vest (3) (in shares) [3] 7,892,000 7,940,000
Stock Options and SARs Exercisable at March 31 (4) (in shares) [4] 3,997,000 3,803,000
Intrinsic Value of Stock Options/SARs Exercised [1] $ 1,100 $ 28,400
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding (in years) 4 years 2 months 12 days 4 years 3 months 18 days
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest [1] $ 51,100 $ 166,100
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) 4 years 1 month 6 days 4 years 2 months 12 days
Aggregate Intrinsic Value for Exercisable Units [1] $ 43,100 $ 110,800
Weighted average remaining contractual life for exercisable options/SARs (in years) 2 years 8 months 12 days 2 years 7 months 6 days
Weighted Average Grant Price Stock Option and SARs [Rollforward]    
Intrinsic Value of Stock Options/SARs Outstanding [1] $ 51,800 $ 170,700
Outstanding at January 1 (price per share) $ 96.90 $ 83.89
Granted (price per share) 96.67 106.76
Exercised (1) (price per share) [1] 69.94 74.65
Forfeited (price per share) 105.43 91.94
Outstanding at March 31 (2) (price per share) [2] 96.99 84.70
Vested or Expected to Vest (3) (price per share) [3] 96.53 84.38
Exercisable at March 31 (4) (price per share) [4] 86.25 76.16
ESPP    
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]    
Weighted Average Fair Value of Grants (price per share) $ 22.98 $ 23.27
Expected Volatility (in hundredths) 36.31% 22.04%
Risk-Free Interest Rate (in hundredths) 2.48% 1.60%
Dividend Yield (in hundredths) 0.83% 0.66%
Expected Life (in years) 6 months 6 months
Restricted Stock And Restricted Stock Units    
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Unrecognized compensation expense [1] $ 182,800  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 1 year 10 months 24 days  
Intrinsic value released during the year [1] $ 22,000 $ 28,400
Aggregate intrinsic value of stock and units outstanding [1] 370,200 403,500
Restricted Stock/Restricted Stock Units [Roll Forward]    
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost [1] $ 23,300 $ 22,400
Outstanding at January 1 (in shares) 3,792,000 3,905,000
Granted (in shares) 371,000 279,000
Released (1) (in shares) [5] (247,000) (276,000)
Forfeited (in shares) (26,000) (75,000)
Outstanding at March 31 (2) (in shares) [6] 3,890,000 3,833,000
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]    
Outstanding at January 1 (price per share) $ 96.64 $ 88.57
Granted (price per share) 96.72 102.27
Released (1) (price per share) [5] 93.37 66.46
Forfeited (price per share) 98.11 90.65
Outstanding at September 30 (2) (price per share) [6] $ 96.85 $ 91.12
Performance Unit    
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Stock-Based Compensation Expenses [1] $ 1,900 $ 1,100
Unrecognized compensation expense $ 7,900  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 1 year 7 months 6 days  
Aggregate intrinsic value of stock and units outstanding $ 58,100 $ 60,400
Minimum Performance Units and Stock Allowed to be Outstanding 287  
Maximum Performance Units and Stock Allowed to be Outstanding 934  
Restricted Stock/Restricted Stock Units [Roll Forward]    
Outstanding at January 1 (in shares) 539 502
Granted (in shares) 0 0
Granted for Performance Multiple (1) [7] 72 72
Released (1) (in shares) 0 0
Forfeited (in shares) 0 0
Outstanding at March 31 (2) (in shares) [8] 611 [9] 574
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]    
Outstanding at January 1 (price per share) $ 101.53 $ 90.96
Granted (price per share) 0.00 0.00
Granted for Performance Multiple (1) (in dollars per share) [7] 69.43 101.87
Released (1) (price per share) 0.00 0.00
Forfeited (price per share) 0.00 0.00
Outstanding at September 30 (2) (price per share) [8] $ 97.75 $ 92.33
Performance Units and Performance Stock Disclosures [Abstract]    
Performance Period for Performance Units and Shares 3 years  
Minimum Performance Multiple at the Completion of the Performance Period 0.00%  
Maximum Performance Multiple at the Completion of the Performance Period 200.00%  
Lease and Well    
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 13,700 $ 12,800
Gathering and Processing Costs    
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Stock-Based Compensation Expenses 200 100
Exploration Costs    
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Stock-Based Compensation Expenses 6,500 6,900
General and Administrative    
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 18,700 $ 15,700
[1] The total intrinsic value of stock options/SARs exercised for the three months ended March 31, 2019 and 2018 was $1.1 million and $28.4 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at March 31, 2019 and 2018 was $51.8 million and $170.7 million, respectively. At March 31, 2019 and 2018, the weighted average remaining contractual life was 4.2 years and 4.3 years, respectively.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at March 31, 2019 and 2018 was $51.1 million and $166.1 million, respectively. At March 31, 2019 and 2018, the weighted average remaining contractual life was 4.1 years and 4.2 years, respectively.
[4] The total intrinsic value of stock options/SARs exercisable at March 31, 2019 and 2018 was $43.1 million and $110.8 million, respectively. At March 31, 2019 and 2018, the weighted average remaining contractual life was 2.7 years and 2.6 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released for the three months ended March 31, 2019 and 2018 was $22.0 million and $28.4 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at March 31, 2019 and 2018 was $370.2 million and $403.5 million, respectively.
[7] Upon completion of the Performance Period for the performance units granted in 2015 and 2014, a performance multiple of 200% was applied to each of the grants resulting in additional grants of performance units in February 2019 and February 2018, respectively.
[8] The total intrinsic value of performance units outstanding at March 31, 2019 and 2018 was approximately $58.1 million and $60.4 million, respectively.
[9] Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of 287 and a maximum of 934 performance units could be outstanding.